| GSM4988752 |
F1A3: Sensitive PH039 first passage niraparib treated tumor |
| GSM4988753 |
F1A4: Sensitive PH039 first passage niraparib treated tumor |
| GSM4988754 |
F1A5: Mixed phenotype PH039 first passage niraparib treated tumor |
| GSM4988755 |
F251: Mixed phenotype PH039 first passage niraparib treated tumor |
| GSM4988756 |
F351: Resistant PH039 second passage niraparib treated tumor |
| GSM4988757 |
F352: Resistant PH039 second passage niraparib treated tumor |
| GSM4988758 |
F451: Resistant PH039 third passage niraparib treated tumor |
| GSM4988759 |
F452: Resistant PH039 third passage niraparib treated tumor |
| GSM4988760 |
F453: Resistant PH039 third passage niraparib treated tumor |
| GSM5025301 |
S0.1: Sensitive PH039 source tumor (array) |
| GSM5025302 |
S0.2: Sensitive PH039 source tumor (array) |
| GSM5025303 |
S2.1: Sensitive PH039 second passage source tumor (array) |
| GSM5025304 |
S2.3-rep1: Sensitive PH039 second passage source tumor (array) |
| GSM5025305 |
C1.2: Sensitive PH039 first passage niraparib treated tumor (array) |
| GSM5025306 |
C2.1: PH039 second passage niraparib treated tumor (array) |
| GSM5025307 |
C2.2: PH039 second passage niraparib treated tumor (array) |
| GSM5025308 |
C3.1: Resistant PH039 third passage niraparib treated tumor (array) |
| GSM5025309 |
148B: Murine sample (array) |
| GSM5025310 |
S2.3-rep2: Sensitive PH039 second passage source tumor (array) |
| GSM5025311 |
S0.2: Sensitive PH039 source tumor (rrbs) |
| GSM5025312 |
S2.1: Sensitive PH039 second passage source tumor (rrbs) |
| GSM5025313 |
S5.3: Sensitive PH039 fifth passage source tumor (rrbs) |
| GSM5025314 |
S5.4: Sensitive PH039 fifth passage source tumor (rrbs) |
| GSM5025315 |
C1.1: PH039 first passage niraparib treated tumor (rrbs) |
| GSM5025316 |
C1.2: PH039 first passage niraparib treated tumor (rrbs) |
| GSM5025317 |
C2.1: PH039 second passage niraparib treated tumor (rrbs) |
| GSM5025318 |
C2.2: PH039 second passage niraparib treated tumor (rrbs) |
| GSM5025319 |
C3.1: Resistant PH039 third passage niraparib treated tumor (rrbs) |
| GSM5025320 |
C3.2: Resistant PH039 third passage niraparib treated tumor (rrbs) |
| GSM5025321 |
C4.2: Resistant PH039 fourth passage niraparib treated tumor (rrbs) |
| GSM5025322 |
C4.3: Resistant PH039 fourth passage niraparib treated tumor (rrbs) |
Less...
More...